In today’s fast-paced and competitive environment, companies are continuously looking for ways to maximize growth, while taking into consideration an increasingly complex environment. As such, companies are turning to public–private partnerships (PPPs).

Amethyst has extensive experience establishing mutually beneficial, long-term partnerships with public, private and not-for-profit medical institutions to offer cancer patients state-of-the-art radiotherapy treatments.

We are a firm believer that PPPs host many benefits, including improved operation and efficiency, long-term value for money created through appropriate risk sharing and alternative sources of funding for public services. Public authorities are giving concession for the achievement of a mission with a strong social impact

However, it is clear the benefits of PPPs are not limited to healthcare. For example, the need for new or upgraded infrastructure, the demand for additional skills or expanded service capacity as well as the need for a stronger supply chain are applicable across many industries such as transport, energy and power, and building and infrastructure.

Enhanced service quality and accessibility

Firstly, PPPs can lead to scalable growth through their ability to enhance service quality and accessibility. Government owned and run organizations can often find themselves in a state of disrepair, lacking the budgets to finance renovation or implement new technologies. In this instance, a PPP means governments and publicly owned institutions can gain more access to flexible and innovative practices.

Amethyst Healthcare Group CEO Stéphane Carré

An example of this at Amethyst is that we recently partnered with a public hospital in France, the Centre Hospitalier de Troyes, where we will operate their radiotherapy treatment center. This partnership will see our expert radiotherapy treatments offered in a public hospital, meaning more patients can access better treatment outcomes, enhancing service quality and accessibility.

PPPs such as these can drive innovation and efficiency by bringing together the strengths of both the public and private sectors. Where the private sector can bring new technologies and management practices, the public sector can provide policy, authorization and licenses as well as governance expertise.

For instance, our acquisition of the Queen Square Radiosurgery Centre in London brings our innovative technology, Gamma Knife therapy, to both private patients and patients referred through the National Health Service (NHS) in England. Consequently, in 2023, we doubled the number of patients treated at the Queen Square Radiosurgery Centre, bringing new technology and more capacity to national health systems.

Public health systems like the NHS should increasingly consider partnerships with the private sector to enhance service delivery and help them meet targets. PPPs in this sector could help to alleviate the strain on services, such as the 18-week target for hospital treatment on the NHS, which has not been met since 2016.

Similarly, in other industries, PPPs implemented in this way means that more service users can access better solutions. Therefore, PPPs can enhance service quality and accessibility across sectors, assisting both partners in meeting targets and working toward sustainable growth as well as patients or users seeking quicker, more effective solutions.

Improved sustainability and scalable growth

By bringing together different stakeholders, PPPs can help create a long-term framework for sustainability. This is because, in a PPP, public and private entities work together to ensure the success of the project.

For example, the private party may encourage the public party to take risks that it would otherwise not take, such as the adoption of innovative technologies. As a result, both the public and private parties are expected to increase their profit, through increasing productivity, which contributes to economic growth and investment capacity.

Specifically, at Amethyst, our PPPs allow us to help public facilities to invest where they otherwise might not be able to. We invest on their behalf and run the centers on their behalf. This allows them to provide the most up-to-date treatment at the most convenient location to offer the best solution for their patients.

Our partnership with the NHS has meant we’ve seen an 84 percent increase in the number of patients we treat annually since 2020, with a 70.1 percent increase in NHS patients. This enables us and the health service to deliver high-quality care, drive down wait times and improve patient outcomes.

Additionally, our PPP model means we are set to continue our fast growth and reach 50 clinics and over 100 linear accelerators in the medium-term.

A crucial role in our future

PPPs have emerged as a vital strategy for companies seeking to maximize growth in today’s competitive environment. I believe Amethyst is a great example of how successful collaborations and aligned interests can enhance operational efficiency while improving outcomes for all parties.

By combining the strengths of both public and private entities across any number of industries, PPPs drive innovation and accessibility while promoting sustainability and scalable growth. Amethyst’s initiatives demonstrate how these collaborations can lead to significant advancements in service quality and capacity.

As more industries recognize the potential of PPPs to meet their goals sustainably, these partnerships are set to play an increasingly crucial role in fostering economic development and improving public services worldwide.

For further information, please contact:

Sophie Ward   Amethyst Healthcare Group